Former OpenAI science lead launches Warp Science to automate wet labs with robots

Former OpenAI science lead Kevin Weil has launched Warp Sciences, a new AI startup focused on automating lab work for drug discovery. The company, which trains robots to make and test promising compounds identified by researchers, has raised $215 million at an $865 million valuation, according to Weil, who announced the startup and funding on X.

The round was led by Lightspeed, with participation from IVP, Premji Invest, and Lux Capital.

For years, biotech companies have outsourced the most labor-intensive…